Authors: Kateřina Tkáčová Authors‘ workplace: LDN Nemocnice Valtice s. r. o. Published in: Geriatrie a Gerontologie 2026, 15, č. 1: 38-43 doi: https://doi.org/10.61568/geri/50-6703/20260311/143077
With advancing age, there is a significant increase in the incidence of thyroid dysfunction, with hypothyroidism being one of the most common endocrine disorders in the elderly. The primary objective of geriatric care is to adopt a comprehensive and individualized patient-centered approach. In geriatric practice, we frequently encounter atypical clinical presentations of hypothyroidism that may be masked by the presence of multiple comorbidities and polypharmacy. As demonstrated in the following case report, the diagnosis of hypothyroidism in polymorbid elderly patients with polypharmacy can be considerably complicated, as its symptoms often overlap with manifestations of other diseases or physiological aging. Early recognition and adequate treatment of hypothyroidism can significantly improve the quality of life of geriatric patients and influence the prognosis of other chronic diseases.
anemia – Hypothyroidism – depression
1. Češka R. Interna. 2., aktualizované vydání. Praha: Grada Publishing; 2015 : 348–349.
2. Bremner AP, Feddema P, Leedman PJ, et al. Age-related changes in thyroid function: a longitudinal study of a community-based cohort. J Clin Endocrinol Metab 2012; 97(5): 1554–1562.
3. Topinková E. Geriatrie pro praxi. 1. vydání. Praha: Grada Publishing; 2005 : 127.
4. Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid 2014; 24(12): 1670–1751.
5. Tessler FN, Middleton WD, Grant EG, et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): white paper of the ACR TI-RADS Committee. J Am Coll Radiol 2017; 14(5): 587– 595.
6. Middleton WD, Langer JE. Thyroid nodules: advances in evaluation and management. Am Fam Physician 2020; 102(5): 298–304.
7. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87(2): 489–499.
8. Roos A, Linn-Rasker SP, van Domburg RT, et al. The starting dose of levothyroxine in primary hypothyroidism treatment: a prospective, randomized, double-blind trial. Arch Intern Med 2005; 165(15): 1714–1720.
9. Duntas LH. Thyroid disease and aging. Minerva Endocrinol 2013; 38(1): 33–40.
10. Pasqualetti G, Pagano G, Rengo G, et al. Subclinical hypothyroidism and cognitive impairment: systematic review and meta-analysis. J Clin Endocrinol Metab 2015; 100(11): 4240–4248.
11. Rieben C, Segna D, da Costa BR, et al. Subclinical thyroid dysfunction and the risk of cognitive decline: a meta-analysis of prospective cohort studies. J Clin Endocrinol Metab 2016; 101(12): 4945–4954.
12. Erdogan M, Kosenli A, Ganidagli S, et al. Characteristics of anemia in subclinical and overt hypothyroid patients. Endocr J 2012; 59(3): 213–220.
13. Bartalena L, Bogazzi F, Chiovato L, et al. 2018 European Thyroid Association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction. Eur Thyroid J 2018; 7(2): 55–66.
14. Canaris GJ, Manowitz NR, Mayor G, et al. The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160(4): 526–534.
15. Virgini VS, Wijsman LW, Rodondi N, et al. Subclinical thyroid dysfunction and functional capacity among elderly. Thyroid 2014; 24(2): 208–214.
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
